Clinical trial Recruiting at 1 site Observational Ages 21 to 45 Women only

Understanding Gestational Diabetes in Asian Pregnant Women

Official title: Studying the Heterogeneity of Gestational Diabetes Mellitus: Cardio-Metabolic Alteration and Treatment Response in a Multi-Ethnic Population in Singapore (GDM-CARE)

Run by National University Health System, Singapore · NCT06542718 · Data updated 2026-11-12

This study is trying to learn more about gestational diabetes in Asian pregnant women to see how different types of the condition affect their health and treatment options.

More Pregnancy Related trials

Quick facts

Study typeObservational
Ages21 Years to 45 Years
SexWomen only
Enrollment800 (estimated)
SponsorNational University Health System, Singapore
Academic / other
Locations1 site (Singapore)
StatusRecruiting
StartedOctober 3, 2022
Main results expectedJune 30, 2026
Study endsJuly 1, 2026
Registry record updatedMay 28, 2025
Trial IDNCT06542718 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are overweight or obese pregnant women of Chinese, Malay, or Indian ethnicity, aged 21-45, who are within the first trimester of pregnancy.

Probably not a fit

Patients who are not Singapore citizens or permanent residents, or those with a history of Type 1 or Type 2 diabetes, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on gestational diabetes mellitus (GDM), a condition that affects pregnant women and can lead to serious health issues for both mothers and babies. It aims to identify different phenotypes of GDM among Asian women by analyzing their cardio-metabolic profiles and treatment responses during pregnancy. Utilizing advanced technologies like continuous glucose monitoring and metabolite profiling, the study seeks to provide insights that could lead to more personalized treatment strategies for managing GDM. By understanding the heterogeneity of GDM, the researchers hope to improve clinical outcomes for affected mothers and their children.

Why it matters

Potential benefit: If successful, this study could lead to more effective and tailored treatment strategies for managing gestational diabetes in pregnant women.

How similar studies have gone: While the approach of defining GDM phenotypes is innovative, similar studies have shown promise in understanding the complexities of gestational diabetes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Gestational age of ≤ 13 weeks 6 days
* Overweight and obese subjects with BMI of 23kg/m² - 24.9kg/m² and ≥ 25.0kg/m², respectively
* Aged 21-45 years with singleton pregnancy
* Plan to be followed up during the whole pregnancy and deliver at NUH
* Chinese, Malay or Indian ethnicity for pregnant subject
* Can complete questionnaires in English language
* Willing to wear continuous glucose monitoring device at least for 7 days at each required clinic visit

Exclusion Criteria:

* Participants who are not Singapore citizens or Singapore Permanent Residents, not intending to eventually deliver in Singapore National University Hospital and to reside in Singapore for the next 2 years
* Have serious skin conditions (eg. eczema) that precludes wearing the sensor for 14 days
* With history of Type 1 diabetes or Type 2 diabetes
* With chronic preexisting life-threatening conditions including pancreatic cancer, end-stage kidney dysfunction, and psychosis
* Unable to read or speak English

Where it's running

  • Department of Obstetrics & Gynaecology
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.